CONNEQT Pulse Validation Study

Launched by MOUNT CARMEL HEALTH SYSTEM · Aug 16, 2023

Keywords

ClinConnect Summary

The CONNEQT Pulse Validation Study is a research trial aimed at testing a new blood pressure monitoring system called CONNEQT Pulse to see how accurately it measures blood pressure in pregnant women. This study compares the CONNEQT Pulse system to a traditional method known as the auscultatory sphygmomanometer, which is often considered the gold standard for measuring blood pressure. The goal is to ensure that the new system provides reliable readings for women who may be experiencing conditions like pre-eclampsia or gestational hypertension during their pregnancy.

To participate in this study, women must be at least 18 years old and in the second or third trimester of pregnancy (more than 12 weeks along). They should also be able to give informed consent to join the study. Participants will include those with normal blood pressure and those with high blood pressure or pre-eclampsia. By joining this trial, women can help researchers improve blood pressure monitoring during pregnancy, which is important for the health of both the mother and the baby. If you or someone you know is interested in participating, it could be a valuable opportunity to contribute to medical research.

Gender

FEMALE

Eligibility criteria

• All Groups:
• • 1. Able to provide informed consent
• • 2. Pregnant patient, beyond the first trimester (greater than 12 weeks of gestation)
• • 3. 18 years of age, or older
• Normotensive:
• • 1. Systolic blood pressure \<140 mmHg (18,66 kPa) and diastolic blood pressure \<90 mmHg (12 kPa)
• Hypertensive:
• • 1. Without proteinuria \>300 mg in 24 h; and
• • 2. With systolic blood pressure ≥140 mmHg (18,66 kPa) or diastolic blood pressure ≥ 90 mmHg (12 kPa)
• Pre-Eclampsia:
• • 1. With proteinuria \>300 mg in 24 h; and
• • 2. With systolic blood pressure ≥140 mmHg (18,66 kPa) or diastolic blood pressure ≥ 90 mmHg (12,00 kPa)